Market Cap

Labomar S.p.A. Market Capitalization:

€184.8 Million

EUR as of July 1, 2023

US$201.8 Million

business Labomar S.p.A. Company Profile

Labomar S.p.A. Main Stock Listing

MTA: LBM

Market Capitalization History of Labomar S.p.A.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Labomar S.p.A. market cap

Date Market Cap YoY Change
Jan. 1, 2023 €156.0 M -9.25%
Jan. 1, 2022 €171.9 M 27.40%
Jan. 1, 2021 €134.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Labomar S.p.A. Categories

Italy languages Healthcare languages Drug Manufacturers—Specialty & Generic
Italy Healthcare Italy Drug Manufacturers—Specialty & Generic

Stocks & Indices

Labomar S.p.A. has the following listings and related stock indices.


Stock: MTA: LBM

Stock: FSX: 6I7

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.